P&G Health Q1 Results 2027: Revenue Rises 7% YoY, PAT Jumps 45% to ₹96 Cr
Procter & Gamble Health reported Q1 FY27 revenue of ₹364 crore, up 7.37% YoY, while PAT jumped 45.29% to ₹96 crore. Check key highlights, EBITDA margin, and quarterly performance.
Procter & Gamble Health Q1 Results FY2027: Procter & Gamble Health reported a healthy performance in Q1 FY27, supported by steady revenue growth and higher profitability. Despite a sequential decline in operating margin, the company delivered strong growth in net profit during the quarter.
Procter & Gamble Health Q1 Results FY2027: On 6 August 2026, Procter & Gamble Health announced its financial results for the first quarter ended 30 June 2026. Revenue from Operations increased 7.37% YoY to ₹364 crore compared with ₹339 crore in Q1 FY26.
While Profit After Tax (PAT) increased 45.29% YoY to ₹96 crore compared with ₹66 crore in Q1 FY26. EBITDA Margin stood at 27.38% during the quarter.
Procter & Gamble Health share price is trading 5% lower on 6 August 2026 at the time of writing this article. The stock has delivered 7% returns year-to-date and -1% returns over the one year from 6 August 2025 to 6 August 2026.
As of 6 Aug, 2:35 PM
READ THIS ALSO: Trent Q1 Results 2027
Procter & Gamble Health Q1 FY27 Results Highlights
-
Revenue from Operations stood at ₹364 crore, registering a 7.37% YoY increase from ₹339 crore in Q1 FY26. Compared with ₹370 crore in Q4 FY26, revenue declined 1.82% QoQ.
-
Total Revenue stood at ₹368 crore, registering a 7.24% YoY increase from ₹343 crore in Q1 FY26. Compared with ₹374 crore in Q4 FY26, total revenue declined 1.83% QoQ.
-
EBITDA (Excluding Other Income) stood at ₹100 crore, compared with ₹90 crore in Q1 FY26, registering a 10.25% YoY increase. Compared with ₹136 crore in Q4 FY26, EBITDA declined 26.54% QoQ.
-
EBITDA Margin stood at 27.38%, compared with 26.67% in Q1 FY26 and 36.60% in Q4 FY26, improving by 0.72 percentage points YoY and declining by 9.22 percentage points QoQ.
-
Profit After Tax (PAT) stood at ₹96 crore, compared with ₹66 crore in Q1 FY26, registering a 45.29% YoY increase. Compared with ₹95 crore in Q4 FY26, PAT increased 1.64% QoQ.
-
PAT Margin stood at 26.44%, compared with 19.54% in Q1 FY26 and 25.54% in Q4 FY26, improving by 6.90 percentage points YoY and 0.90 percentage points QoQ.
-
EPS stood at ₹57.92, compared with ₹39.87 in Q1 FY26 and ₹56.99 in Q4 FY26, increasing 45.27% YoY and 1.63% QoQ
|
Metric |
Q1 FY27 |
Q4 FY26 |
QoQ % |
Q1 FY26 |
YoY % |
|---|---|---|---|---|---|
|
Revenue from Operations (₹ Cr) |
364 |
370 |
-1.82% |
339 |
7.37% |
|
Total Revenue (₹ Cr) |
368 |
374 |
-1.83% |
343 |
7.24% |
|
EBITDA (Excl. Other Income) (₹ Cr) |
100 |
136 |
-26.54% |
90 |
10.25% |
|
EBITDA Margin |
27.38% |
36.60% |
-9.22 pp |
26.67% |
+0.72 pp |
|
PAT (₹ Cr) |
96 |
95 |
1.64% |
66 |
45.29% |
|
PAT Margin |
26.44% |
25.54% |
+0.90 pp |
19.54% |
+6.90 pp |
|
EPS (₹) |
57.92 |
56.99 |
1.63% |
39.87 |
45.27% |
Source: Company Filing
All topics
Click the link, confirm the box next to sahi.com is checked — ignore any other results.